FDA Inspection
Sanit Technologies, LLC dba DurisanSanit Technologies, LLC dba Durisan – FDA Inspection, May 17, 2019
Record Details
This FDA Inspection record concerns Sanit Technologies, LLC dba Durisan, with an inspection on May 17, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c064652e-92a7-4d16-a935-f816eaa094d9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1089903
- FDA center
- Human Drugs
- Project area
- Over-the-Counter Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
9- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.67(c)Cleaning/maintenance records not kept
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.165(c)Sampling and testing plans not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sanit Technologies, LLC dba Durisan
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sanit Technologies, LLC dba Durisan
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.